Gene Transfer
Vectors encoding for angiostatin and endostatin surpass single-encoded vectors
Published in Gene Therapy Weekly, April 22nd, 2004
According to published research from the United States, "angiogenesis is characteristic of solid tumor growth and a surrogate marker for metastasis in many human cancers. Inhibition of tumor angiogenesis using antiangiogenic drugs and gene transfer approaches has suggested the potential of this form of therapy in controlling tumor growth. However, for long-term tumor-free survival by antiangiogenic therapy, the factors controlling tumor neovasculature need to be systemically maintained at stable therapeutic levels."
"Here we show sustained expression of the antiangiogenic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-04-22)
More Articles from Gene Therapy Weekly
- Gastroenterology
Inducible nitric oxide synthase sensitizes colorectal cancer to radiation - Gynecology
The ceruloplasmin promoter shows an affinity for ovarian tumors - Biological Therapy
Silenced clusterin-apolipoprotein J gene causes cancer cells to implode - Gene Transfer
A new cleavage product gives real-time information about transgene activity - Immunology
Gene therapy in a murine multiple sclerosis model corrects disease - Pediatric Cancer
Herpes simplex virus thymidine kinase genes diminish nearby neuroblastoma cells - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
